Sonoma Pharmaceuticals shares surge 72.02% intraday after launching HOCl diaper rash product in 3600 Walmart stores and Amazon.

Sonoma Pharmaceuticals, Inc. surged 72.02% intraday after announcing the launch of a HOCl diaper rash product based on Microcyn technology, which will be available in 3,600 Walmart stores and on Amazon. The company specializes in developing and producing stable hypochlorous acid (HOCl) products for wound care, skin care, and over-the-counter medical applications. Additionally, the company reported first-quarter revenue of $401.5 million, up 18.4% year-over-year.